MaxCyte (MXCT) News Today $1.42 +0.07 (+4.78%) As of 03:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MXCT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Insider Buying: MaxCyte, Inc. (NASDAQ:MXCT) CFO Acquires 50,000 Shares of StockAugust 15 at 8:44 PM | marketbeat.comInsider Buying: MaxCyte, Inc. (NASDAQ:MXCT) Director Buys 50,000 Shares of StockAugust 15 at 8:44 PM | marketbeat.comMaxCyte, Inc. (NASDAQ:MXCT) CEO Maher Masoud Buys 75,000 SharesAugust 15 at 8:44 PM | marketbeat.comRichard Douglas Purchases 80,000 Shares of MaxCyte, Inc. (NASDAQ:MXCT) StockAugust 15 at 8:44 PM | marketbeat.comStanley C. Erck Acquires 100,000 Shares of MaxCyte, Inc. (NASDAQ:MXCT) StockAugust 15 at 8:44 PM | marketbeat.comInsider Buying: MaxCyte, Inc. (NASDAQ:MXCT) CFO Acquires 50,000 Shares of StockAugust 14, 2025 | insidertrades.comMaxCyte (NASDAQ:MXCT) Receives Neutral Rating from BTIG ResearchAugust 14, 2025 | americanbankingnews.comMaxCyte's (MXCT) "Neutral" Rating Reiterated at BTIG ResearchAugust 12, 2025 | marketbeat.comMaxCyte (MXCT) Signed a Strategic Platform License with Adicet BioAugust 11, 2025 | msn.comMaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street ZenAugust 11, 2025 | americanbankingnews.comMaxCyte (NASDAQ:MXCT) Lowered to Sell Rating by Wall Street ZenAugust 10, 2025 | marketbeat.comGagnon Advisors LLC Purchases New Shares in MaxCyte, Inc. (NASDAQ:MXCT)August 9, 2025 | marketbeat.comGagnon Securities LLC Acquires 850,992 Shares of MaxCyte, Inc. (NASDAQ:MXCT)August 8, 2025 | marketbeat.comMaxCyte, Inc. (MXCT) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comMaxCyte (MXCT) Q2 Revenue Drops 18%August 6, 2025 | fool.comMaxCyte Inc (MXCT) Q2 2025 Earnings Report Preview: What To ExpectAugust 6, 2025 | finance.yahoo.comMaxCyte Signs Platform License Agreement with Adicet BioAugust 4, 2025 | globenewswire.comMaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy PipelineJuly 31, 2025 | globenewswire.comMaxCyte (MXCT) to Release Earnings on WednesdayJuly 30, 2025 | marketbeat.comRoyce & Associates LP Has $2.84 Million Holdings in MaxCyte, Inc. (NASDAQ:MXCT)July 28, 2025 | marketbeat.comStephens Initiates Coverage on MaxCyte (NASDAQ:MXCT)July 22, 2025 | marketbeat.comCenterBook Partners LP Lowers Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT)July 16, 2025 | marketbeat.comRice Hall James & Associates LLC Has $1.24 Million Position in MaxCyte, Inc. (NASDAQ:MXCT)July 15, 2025 | marketbeat.comMaxCyte to Report Second Quarter 2025 Financial Results ... - MorningstarJuly 11, 2025 | morningstar.comMMaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - NasdaqJuly 10, 2025 | nasdaq.comMaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6thJuly 9, 2025 | quiverquant.comQMaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025July 9, 2025 | globenewswire.comPHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in JapanJuly 1, 2025 | businesswire.comChevy Chase Trust Holdings LLC Has $6.09 Million Stake in MaxCyte, Inc. (NASDAQ:MXCT)June 27, 2025 | marketbeat.comMaxCyte and Ori Biotech Forge Strategic Partnership to Enhance Cell Therapy Manufacturing EfficiencyJune 12, 2025 | nasdaq.comMaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular TherapiesJune 11, 2025 | globenewswire.comMaxCyte (NASDAQ:MXCT) Rating Increased to Hold at Wall Street ZenJune 8, 2025 | marketbeat.comMaxCyte Expands Stock Capital Amidst Strategic GrowthJune 2, 2025 | tipranks.comMaxCyte (NASDAQ:MXCT) Downgraded to "Sell" Rating by Wall Street ZenJune 1, 2025 | marketbeat.comMillennium Management LLC Sells 1,451,994 Shares of MaxCyte, Inc. (NASDAQ:MXCT)May 26, 2025 | marketbeat.comMaxCyte, Inc. (NASDAQ:MXCT) Shares Sold by Lazard Asset Management LLCMay 23, 2025 | marketbeat.comDimensional Fund Advisors LP Has $5.95 Million Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT)May 13, 2025 | marketbeat.comWilliam Blair Predicts MaxCyte's Q2 Earnings (NASDAQ:MXCT)May 13, 2025 | marketbeat.comMaxCyte, Inc. (MXCT) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comAxa S.A. Makes New $4.11 Million Investment in MaxCyte, Inc. (NASDAQ:MXCT)May 10, 2025 | marketbeat.comMaxCyte, Inc.: MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 GuidanceMay 7, 2025 | finanznachrichten.deMaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 GuidanceMay 7, 2025 | globenewswire.comCadian Capital Management LP Buys 1,155,476 Shares of MaxCyte, Inc. (NASDAQ:MXCT)May 7, 2025 | marketbeat.comMaxCyte Expands Stock Capital with New Share IssuanceMay 2, 2025 | tipranks.comMaxCyte (MXCT) Expected to Announce Quarterly Earnings on WednesdayMay 2, 2025 | marketbeat.comRenaissance Technologies LLC Has $1.17 Million Stock Position in MaxCyte, Inc. (NASDAQ:MXCT)May 2, 2025 | marketbeat.comWalleye Capital LLC Invests $461,000 in MaxCyte, Inc. (NASDAQ:MXCT)April 26, 2025 | marketbeat.comBlackRock Adjusts Stake in MaxCyte, Inc.April 22, 2025 | tipranks.comMirabella Financial Services LLP Takes $15.39 Million Position in MaxCyte, Inc. (NASDAQ:MXCT)April 22, 2025 | marketbeat.comVanguard Group Inc. Sells 345,587 Shares of MaxCyte, Inc. (NASDAQ:MXCT)April 17, 2025 | marketbeat.com Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address MXCT Media Mentions By Week MXCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MXCT News Sentiment▼1.300.65▲Average Medical News Sentiment MXCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MXCT Articles This Week▼153▲MXCT Articles Average Week Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Next Technology News Pursuit Attractions and Hospitality News Riskified News Fiverr International News Cars.com News NerdWallet News Montrose Environmental Group News Uxin News Enviri News Paysafe News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MXCT) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access